26
Participants
Start Date
January 5, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
BL-M07D1
Administration by intravenous infusion
RECRUITING
Fudan University ShangHai Cancer Center, Shanghai
SystImmune Inc.
INDUSTRY
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.
INDUSTRY
Sichuan Baili Pharmaceutical Co., Ltd.
INDUSTRY